Immunogen, inc. (IMGN)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Jan'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11
ASSETS
Cash and cash equivalents

247,300

176,200

204,500

239,800

270,396

262,300

303,205

345,058

218,383

267,107

267,107

194,851

150,337

126,568

159,964

196,000

245,026

182,913

212,283

247,843

278,109

111,827

106,604

121,798

142,261

164,076

178,088

174,838

194,960

206,103

211,021

233,614

160,938

175,260

168,372

179,765

191,206

Accounts receivable

54

7,500

94

-

233

1,701

2,115

19

34

2,649

2,649

2,521

1,024

3,893

2,026

316

883

104

803

6,812

5,088

754

3,109

1,838

1,896

36

3,818

5,789

-

5,446

1,286

853

129

1,430

21,214

1

4,668

Unbilled revenue/reimbursement

1,753

1,001

3,009

2,474

3,982

617

521

522

2,838

2,580

2,580

2,600

1,807

2,051

6,778

1,460

1,409

1,027

885

899

714

536

578

784

1,329

1,987

1,904

1,979

2,121

2,105

2,006

1,446

1,196

1,284

975

1,098

1,488

Contract asset

990

3,631

0

0

-

500

500

-

4,041

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash royalty receivable

12,977

15,116

13,126

10,430

8,514

9,249

8,115

7,236

16,090

8,900

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

-

-

-

-

-

-

1,938

1,890

368

1,038

1,038

2,243

3,482

3,225

2,192

2,027

907

908

1,537

1,246

2,935

2,702

1,919

2,115

2,950

2,484

3,008

1,671

703

112

450

170

1,288

931

1,106

1,147

480

Current portion of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,018

1,120

1,136

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

319

319

319

319

319

319

319

319

319

319

319

1,019

Prepaid and other current assets

7,653

5,425

4,961

6,649

6,710

4,462

6,320

9,893

5,680

2,967

2,967

4,745

4,758

6,394

5,386

7,481

4,881

7,334

6,618

4,080

4,175

3,309

2,153

1,795

2,320

3,442

2,321

3,140

2,581

1,622

1,976

2,419

2,400

2,588

1,594

1,279

2,664

Total current assets

270,726

208,898

225,681

259,378

289,835

278,781

322,714

364,618

247,434

285,241

276,341

206,960

161,408

142,131

176,346

207,284

253,106

193,304

223,246

262,016

291,021

119,128

114,363

128,330

150,756

172,344

189,458

187,736

200,684

215,707

217,058

238,821

166,270

181,812

193,580

183,609

201,525

Property and equipment, net of accumulated depreciation

6,018

6,993

9,118

10,052

13,720

12,891

13,209

12,029

12,850

14,538

14,538

15,622

16,821

17,997

19,498

20,931

22,704

22,404

21,518

18,510

16,254

14,631

14,128

14,668

14,349

12,046

10,753

10,173

10,783

10,561

11,352

11,442

11,633

11,751

11,949

12,805

13,409

Operating lease right-of-use assets

15,200

15,587

15,900

16,400

16,705

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,714

3,874

4,147

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,912

1,912

1,912

1,912

2,231

2,231

2,231

2,231

2,549

2,549

2,549

2,549

Other assets

6,831

3,784

3,413

1,850

3,665

3,709

3,941

4,437

4,681

3,797

3,797

3,113

3,148

3,193

3,020

3,133

3,430

2,925

2,942

911

974

43

49

108

213

392

400

203

217

183

196

174

174

216

141

141

158

Total assets

298,809

235,262

254,136

287,669

323,925

295,381

339,864

381,084

264,965

303,576

294,676

225,695

181,377

163,321

198,864

231,348

279,240

222,347

251,580

285,584

308,249

133,802

128,540

143,106

165,318

186,694

202,523

200,024

213,596

228,682

230,837

252,668

180,308

196,328

208,219

199,104

217,641

LIABILITIES AND SHAREHOLDERS (DEFICIT) EQUITY
Accounts payable

9,534

9,933

7,227

7,809

8,777

11,365

10,352

12,881

7,786

8,562

8,562

6,614

5,152

5,100

7,895

8,973

11,510

10,100

13,404

9,689

8,138

6,322

5,613

4,957

4,819

4,743

3,812

3,122

4,498

2,723

4,706

3,216

3,395

2,635

1,484

2,850

3,213

Accrued compensation

5,211

8,991

13,232

19,564

4,423

11,796

10,316

8,524

5,671

11,473

11,473

8,525

7,212

4,927

6,946

6,746

10,724

6,589

5,455

3,262

8,346

7,171

4,679

3,712

6,865

6,396

4,162

3,276

6,153

5,063

3,173

2,436

4,942

4,113

2,786

2,306

4,723

Other accrued liabilities

18,916

13,932

14,040

14,681

20,629

20,465

24,117

17,865

23,756

15,767

15,767

13,956

12,332

12,078

11,150

10,018

9,713

9,150

7,718

9,631

10,441

7,693

7,606

6,844

6,668

7,221

6,158

6,904

6,049

6,337

4,467

7,421

4,589

3,874

2,982

3,236

3,305

Current portion of deferred lease incentive

-

-

-

-

-

837

832

793

784

784

784

784

784

784

784

784

772

651

646

646

646

646

639

562

528

1,016

979

979

979

979

979

979

979

979

979

979

979

Current portion of liability related to the sale of future royalties, net of deferred financing costs of $557 and $635, respectively

48,651

41,274

35,985

29,484

24,646

25,880

23,040

22,265

27,619

17,779

17,779

16,703

15,678

15,664

14,470

16,070

14,138

13,001

15,132

11,862

6,747

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of operating lease liability

3,071

2,971

2,873

2,761

2,634

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of deferred revenue

123

309

14,817

317

317

317

1,713

1,020

611

1,446

1,405

27,073

26,192

1,814

14,531

13,634

13,582

339

1,545

858

333

980

1,106

23,699

2,374

1,821

2,522

2,260

1,494

1,712

1,303

1,376

2,349

3,197

3,389

3,848

2,346

Total current liabilities

85,506

77,410

88,174

74,616

61,426

70,660

70,370

63,348

66,227

55,811

55,770

73,655

67,350

40,367

55,776

56,225

60,439

39,830

43,900

35,948

34,651

22,812

19,643

39,774

21,254

21,197

17,633

16,541

19,173

16,814

14,628

15,428

16,254

14,798

11,620

13,219

14,566

Deferred lease incentive, net of current portion

-

-

-

-

-

4,675

4,854

4,806

4,933

5,129

5,129

5,325

5,521

5,718

5,914

6,110

6,236

5,836

5,978

6,139

6,301

6,462

6,547

5,904

5,679

5,079

5,137

5,382

5,626

5,871

6,116

6,360

6,605

6,850

7,094

7,339

7,583

Deferred revenue, net of current portion

127,387

127,123

131,035

145,614

145,693

80,485

80,592

80,751

81,522

88,521

93,752

93,832

18,912

18,992

19,086

19,162

19,288

32,015

32,041

40,794

40,855

40,917

20,978

34,661

58,969

59,348

46,487

55,275

63,384

63,297

70,365

69,769

69,761

69,914

70,290

50,856

51,545

Operating lease liability - net of current portion

20,996

21,798

22,578

23,334

24,084

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible 4.5% senior notes, net of deferred financing costs of $18 and $22, respectively

2,082

2,078

2,075

2,071

2,068

2,064

2,060

2,057

2,053

2,050

2,050

3,022

97,299

97,131

96,965

96,794

96,628

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liability related to the sale of future royalties, net of current portion and deferred financing costs of $765 and $859, respectively

65,452

82,267

95,529

108,265

117,785

122,345

130,907

136,701

142,018

151,634

151,634

157,080

161,339

164,460

169,858

171,492

174,761

181,636

182,176

186,967

187,341

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

1,489

707

970

1,943

473

4,180

4,193

4,231

4,523

4,236

4,236

4,076

4,185

4,183

4,115

4,103

4,192

4,173

4,171

4,127

3,997

3,941

3,902

3,796

3,717

3,136

3,230

3,385

3,566

3,698

3,733

3,799

3,798

3,836

3,871

3,919

3,978

Total liabilities

302,912

311,383

340,361

355,843

351,529

284,409

292,976

291,894

301,276

307,381

312,571

336,990

354,606

330,851

351,714

353,886

361,544

263,490

268,266

273,975

273,145

74,132

51,070

84,135

89,619

88,760

72,487

80,583

91,749

89,680

94,842

95,356

96,418

95,398

92,875

75,333

77,672

Commitments and contingencies (Note I)

-

-

-

-

-

-

0

0

0

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Shareholders' deficit:
Preferred stock, $.01 par value; authorized 5,000 shares; no shares issued and outstanding as of March 31, 2020 and December 31, 2020

-

-

-

-

-

-

0

0

0

-

-

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $.01 par value; authorized 200,000 shares; issued and outstanding 174,261 and 150,136 shares as of March 31, 2020 and December 31, 2019, respectively

1,743

1,501

1,498

1,498

1,494

1,494

1,490

1,490

1,330

1,325

1,325

1,156

896

893

873

873

872

871

870

870

866

861

861

859

859

858

856

853

847

844

842

841

778

772

767

764

763

Additional paid-in capital

1,310,710

1,209,846

1,204,559

1,200,860

1,197,988

1,192,813

1,186,934

1,182,429

1,015,464

1,009,362

1,009,362

903,013

784,657

781,492

778,847

775,007

770,511

765,751

758,281

753,349

743,108

737,205

733,387

728,525

722,971

718,708

713,361

706,581

697,767

693,050

688,694

685,619

587,068

581,700

577,450

573,127

569,843

Accumulated deficit

-1,300,000

-1,287,468

-1,300,000

-1,300,000

-1,227,086

-1,183,335

-1,141,536

-1,094,729

-1,053,105

-1,014,492

-1,028,582

-1,015,464

-958,782

-949,915

-932,570

-898,418

-853,687

-807,765

-775,837

-742,610

-708,870

-678,396

-656,778

-670,413

-648,131

-621,632

-584,181

-587,993

-576,767

-554,892

-553,541

-529,148

-503,956

-481,542

-462,873

-450,120

-430,637

Total shareholders? deficit

-4,103

-76,121

-86,225

-68,174

-27,604

10,972

46,888

89,190

-36,311

-3,805

-17,895

-111,295

-173,229

-167,530

-152,850

-122,538

-82,304

-41,143

-16,686

11,609

35,104

59,670

77,470

58,971

75,699

97,934

130,036

119,441

121,847

139,002

135,995

157,312

83,890

100,930

115,344

123,771

139,969

Total liabilities and shareholders? deficit

298,809

235,262

254,136

287,669

323,925

295,381

339,864

381,084

264,965

303,576

294,676

225,695

181,377

163,321

198,864

231,348

279,240

222,347

251,580

285,584

308,249

133,802

128,540

143,106

165,318

186,694

202,523

200,024

213,596

228,682

230,837

252,668

180,308

196,328

208,219

199,104

217,641